The report highlights Nihon Chouzai's commitment to achieving true separation of drug prescribing and dispensing services. The company achieved significant growth in fiscal year 2019, with net sales exceeding 268.5 billion yen and operating profit reaching 7.593 billion yen. The report also focuses on the company's investments in human resources and its commitment to sustainability.
Issuing Company Nihon Chouzai Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 4.63 MB
No. of Pages 48 pages
Reporting periodApril 1, 2019 to March 31, 2020
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI
Materiality Assessmenttrue